Global investment firm The Riverside Company has invested in Avance Clinical, an Australian contract research organisation, while Israel’s EasySend raised $50.5 million in funding.
The Riverside Company invests in Australia’s Avance Clinical
Global investment firm The Riverside Company has invested an undisclosed amount in Avance Clinical (Avance), an Australian contract research organisation (CRO) for international biotech firms, according to an announcement.
